Research Study Search Tool

Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?

Search Results: Prevention, Detection & Risk + Pancreatic Cancer + Screening & Early Detection (6 results)

Here are some research studies that may be enrolling patients like you. Please check with the study contact and your health care provider to confirm your eligibility and see if the study is right for you. Note, our search tool may not be comprehensive and additional research resources can be found here.

GENetic Education Risk Assessment and TEsting Study (GENERATE)

Prevention:
Pancreatic

GENetic Education Risk Assessment and TEsting Study (GENERATE)

The goal of the GENERATE study is to increase the uptake of genetic testing among family members of pancreatic cancer patients who may carry a genetic mutation.

This study involves education about genetic testing, undergoing genetic testing for cancer risk (for those who choose to) and completion of a series of 4 sets of questionnaires.

For more information, visit the study website

Genomic Services Research Program Study for People with Unexpected Genetic Results

Prevention:
Breast
Ovarian
Pancreatic
Prostate

Genomic Services Research Program Study for People with Unexpected Genetic Results

A new study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason.

This is a study of people with "secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk. If you think you have received a secondary result, you may be eligible to join this study.

A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Prevention:
Pancreatic

A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

This study will validate and evaluate the performance of the IMMray PanCan-d test for pancreatic cancer diagnosis in comparison to standard of care imaging currently used in pancreatic cancer disease surveillance by the research sites’ institutions.

A Study in Hereditary Breast and Ovarian  Cancer Families to Provide Men With  Up-To-Date Information About the Personal  Importance of Genetic Testing (GEM)

Prevention:
Pancreatic
Prostate

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up-To-Date Information About the Personal Importance of Genetic Testing (GEM)

The Genetic Education for Men or GEM study, is a clinical trial evaluating educational tools for men from families in which a BRCA1/2 gene mutation has been identified. In order to identify untested men from BRCA1/2 families, we are seeking women who have received positive BRCA1/2 test results and have at least one untested male relative.

Women interested in the study should contact the project coordinator, Mary Kate Ladd, by phone at (877) 687-2720 (toll-free) or by email.

Pancreatic Cancer Early Detection Program

Prevention:
Pancreatic

Pancreatic Cancer Early Detection Program

This is a study looking at esophageal ultrasound and Magnetic Resonance Imaging (MRI) as a screening for pancreatic cancer in high risk individuals. 

PHACT Study: Population Health and Cancer Testing

Prevention:
Breast
Melanoma
Ovarian
Pancreatic
Prostate

PHACT Study: Population Health and Cancer Testing

The PHACT study offers genetic testing to women and men of Ashkenazi (Eastern European) Jewish ancestry, age 21 or older. This group is at least ten times more likely than the general population to inherit certain kinds of genetic mutations associated with cancer risk. The study is open to people who live in one of the nine Bay Area counties (Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, Solano, Sonoma).  By participating in the UCSF Population Health and Cancer Testing (PHACT) study you will be provided with a saliva collection kit from Color Genomics, a genetic laboratory. Thirty genes will be analyzed, including BRCA1 and BRCA2, to identify mutations that increase the chance of cancer in both men and women of Ashkenazi (Eastern European) Jewish ancestry and genetic counseling support will be available with every test.  For more information, visit the UCSF Center for BRCA Research. 

Additional Results on Clinicaltrials.gov: Prevention, Detection & Risk + Pancreatic Cancer + Screening & Early Detection

6 Results

Clinical Trial Official Title
NCT03250078 A Pancreatic Cancer Screening Study in High Risk Individuals
NCT03937453 A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus
NCT03568630 Blood Markers of Early Pancreas Cancer
NCT02206360 Pancreatic Cancer Early Detection Program
NCT03693378 A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
NCT03851133 Florida Pancreas Collaborative Next Generation Biobank

FORCE:Facing Our Risk of Cancer Empowered